[cid:image001.jpg@01D158FE.B69B8D00]
S E M I N A R & V I S I T I N G S P E A K E R S E R I E S
D A T E
Friday, May 31, 2019
9:00 AM
L O C AT I O N
PX236/238 PsycHealth Blding
S P E A K E R
Tamra Ogilvie, Ph.D.<http://umanitoba.ca/medicine/units/biochem/faculty/t_werbowetski-ogilvie.ht…>
Canada Research Chair in Neuro-oncology and Human Stem Cells
Associate Professor, Regenerative Medicine Program
Biochemistry & Medical Genetics and Physiology & Pathophysiology
Max Rady College of Medicine
Rady Faculty of Health Sciences
University of Manitoba
T O P I C
Novel gene networks regulating self-renewal and differentiation in medulloblastoma
A B S T R AC T
OTX2 is a potent oncogenic driver of tumor growth and cell cycle progression in Group 3 medulloblastoma. However, the specific mechanisms by which OTX2 represses neural differentiation in these highly aggressive tumors are not well characterized. We have utilized ChIP-sequencing combined with extensive medulloblastoma patient transcriptome and proteomics data to identify and subsequently validate a novel OTX2 regulatory network that controls Group 3 medulloblastoma cell fate decisions. OTX2 directly restricts the expression of neuronal differentiation genes encoding transcription factors including the novel target genes PAX3 and PAX6. Expression of PAX3 and PAX6 is significantly lower in Group 3 MB patients and is correlated with reduced survival. Similar to OTX2 silencing, PAX3 and PAX6 overexpression inhibit self-renewal and enhance neuronal differentiation in vitro while PAX3, on its own, increases survival in vivo. Finally, we identify mTORC1 and EPHB2 forward signaling as downstream effectors of OTX2-PAX3, thus highlighting axon guidance and protein synthesis pathways as novel therapeutic targets and key players in Group 3 medulloblastoma pathogenesis.
O B J E C T I V E S
* Understand the genetic, molecular and cellular heterogeneity associated with the pediatric brain tumor medulloblastoma
* Understand the multifaceted role of OTX2 in medulloblastoma pathogenesis
* Describe the functional outcome of increased PAX gene expression on medulloblastoma tumorigenic properties in vitro and in vivo
For more information, contact the MNN office @ 204.235.3939
Tabrez Siddiqui
Chair, MNN Seminar Series
E: Tabrez.siddiqui(a)umanitoba.ca<mailto:Tabrez.siddiqui@umanitoba.ca>
Kelly Jorundson
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca>
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
[cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/>
[cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>
cid:image001.jpg@01D158FE.B69B8D00
S E M I N A R & V I S I T I N G S P E A K E R S E R I E S
D A T E
Friday, May 31, 2019
9:00 AM
L O C AT I O N
PX236/238 PsycHealth Blding
S P E A K E R
Tamra Ogilvie, Ph.D.
<http://umanitoba.ca/medicine/units/biochem/faculty/t_werbowetski-ogilvie.ht
ml>
Canada Research Chair in Neuro-oncology and Human Stem Cells
Associate Professor, Regenerative Medicine Program
Biochemistry & Medical Genetics and Physiology & Pathophysiology
Max Rady College of Medicine
Rady Faculty of Health Sciences
University of Manitoba
T O P I C
Novel gene networks regulating self-renewal and differentiation in
medulloblastoma
A B S T R AC T
OTX2 is a potent oncogenic driver of tumor growth and cell cycle progression
in Group 3 medulloblastoma. However, the specific mechanisms by which OTX2
represses neural differentiation in these highly aggressive tumors are not
well characterized. We have utilized ChIP-sequencing combined with extensive
medulloblastoma patient transcriptome and proteomics data to identify and
subsequently validate a novel OTX2 regulatory network that controls Group 3
medulloblastoma cell fate decisions. OTX2 directly restricts the expression
of neuronal differentiation genes encoding transcription factors including
the novel target genes PAX3 and PAX6. Expression of PAX3 and PAX6 is
significantly lower in Group 3 MB patients and is correlated with reduced
survival. Similar to OTX2 silencing, PAX3 and PAX6 overexpression inhibit
self-renewal and enhance neuronal differentiation in vitro while PAX3, on
its own, increases survival in vivo. Finally, we identify mTORC1 and EPHB2
forward signaling as downstream effectors of OTX2-PAX3, thus highlighting
axon guidance and protein synthesis pathways as novel therapeutic targets
and key players in Group 3 medulloblastoma pathogenesis.
O B J E C T I V E S
* Understand the genetic, molecular and cellular heterogeneity
associated with the pediatric brain tumor medulloblastoma
* Understand the multifaceted role of OTX2 in medulloblastoma
pathogenesis
* Describe the functional outcome of increased PAX gene expression on
medulloblastoma tumorigenic properties in vitro and in vivo
For more information, contact the MNN office @ 204.235.3939
Tabrez Siddiqui
Chair, MNN Seminar Series
E: Tabrez.siddiqui(a)umanitoba.ca
Kelly Jorundson
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
cid:image001.jpg@01D158FE.B69B8D00
*TODAY IS YOUR LAST DAY TO REGISTER!
The MNN is pleased to announce that the 2019 Scientific Meeting will be held
JUNE 7. The meeting is co-chaired by Dr. Domenico Di Curzio and Dr. Renée
Douville and will be held at the University of Winnipeg. There is an
engaging program planned, featuring a visit and talk by Canadian Research
Council Chair in Developmental Neurogenetics Dr. Daniel Goldowitz
(University of British Columbia) a public lecture by Dr. Janice Robertson
(University of Toronto), a leading expert in Amyotrophic Lateral Sclerosis
neuropathology and therapeutic development. The scientific event will be
capped off with a networking mixer and neuroscience art silent auction at
the Winnipeg Art Gallery.
Abstracts and registrations are now being accepted. These links and the
program can be found at:
<https://manitobaneuroscience.ca/annual-meeting/2019mnn/>
https://manitobaneuroscience.ca/annual-meeting/2019mnn/
Annual Scientific Meeting | Manitoba Neuroscience Network
manitobaneuroscience.ca
Highlights
Three visiting national speakers
Taco bar lunch (Om nom nom!)
Poster competition
Stellas goodies at coffee breaks
SWAG bags and vendor tables
WAG Networking mixer after-party
Neuroscience art silent auction
And more
Registration takes 5 minutes or less!
NEW this year the student meeting registration rate has been reduced to
only $15. Postdocs and community members are $25 and Faculty are $50.
Discounted rates apply if attending both scientific session and networking
mixer. You may pay by credit card or by University of Manitoba FOP. If you
pay by FOP, you will be registered for the meeting immediately, but your
payment will be pending. Once the FOP payment is processed, you will receive
a receipt and confirmation by email.
MNN Scientific Meeting inquiries should be sent to:
mnn2019(a)manitobaneuroscience.ca
-The MNN Team
Kelly Jorundson
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
cid:image001.jpg@01D158FE.B69B8D00
S E M I N A R & V I S I T I N G S P E A K E R S E R I E S
D A T E
Friday, May 31, 2019
9:00 AM
L O C AT I O N
PX236/238 PsycHealth Blding
S P E A K E R
Tamra Ogilvie, Ph.D.
<http://umanitoba.ca/medicine/units/biochem/faculty/t_werbowetski-ogilvie.ht
ml>
Canada Research Chair in Neuro-oncology and Human Stem Cells
Associate Professor, Regenerative Medicine Program
Biochemistry & Medical Genetics and Physiology & Pathophysiology
Max Rady College of Medicine
Rady Faculty of Health Sciences
University of Manitoba
T O P I C
Novel gene networks regulating self-renewal and differentiation in
medulloblastoma
A B S T R AC T
OTX2 is a potent oncogenic driver of tumor growth and cell cycle progression
in Group 3 medulloblastoma. However, the specific mechanisms by which OTX2
represses neural differentiation in these highly aggressive tumors are not
well characterized. We have utilized ChIP-sequencing combined with extensive
medulloblastoma patient transcriptome and proteomics data to identify and
subsequently validate a novel OTX2 regulatory network that controls Group 3
medulloblastoma cell fate decisions. OTX2 directly restricts the expression
of neuronal differentiation genes encoding transcription factors including
the novel target genes PAX3 and PAX6. Expression of PAX3 and PAX6 is
significantly lower in Group 3 MB patients and is correlated with reduced
survival. Similar to OTX2 silencing, PAX3 and PAX6 overexpression inhibit
self-renewal and enhance neuronal differentiation in vitro while PAX3, on
its own, increases survival in vivo. Finally, we identify mTORC1 and EPHB2
forward signaling as downstream effectors of OTX2-PAX3, thus highlighting
axon guidance and protein synthesis pathways as novel therapeutic targets
and key players in Group 3 medulloblastoma pathogenesis.
O B J E C T I V E S
* Understand the genetic, molecular and cellular heterogeneity
associated with the pediatric brain tumor medulloblastoma
* Understand the multifaceted role of OTX2 in medulloblastoma
pathogenesis
* Describe the functional outcome of increased PAX gene expression on
medulloblastoma tumorigenic properties in vitro and in vivo
For more information, contact the MNN office @ 204.235.3939
Tabrez Siddiqui
Chair, MNN Seminar Series
E: Tabrez.siddiqui(a)umanitoba.ca
Kelly Jorundson
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
cid:image001.jpg@01D158FE.B69B8D00
ONLY THREE DAYS LEFT - REGISTER NOW!
So you dont miss out, we have extended the MNN meeting deadline to May 17.
The MNN is pleased to announce that the 2019 Scientific Meeting will be held
JUNE 7. The meeting is co-chaired by Dr. Domenico Di Curzio and Dr. Renée
Douville and will be held at the University of Winnipeg. There is an
engaging program planned, featuring a visit and talk by Canadian Research
Council Chair in Developmental Neurogenetics Dr. Daniel Goldowitz
(University of British Columbia) a public lecture by Dr. Janice Robertson
(University of Toronto), a leading expert in Amyotrophic Lateral Sclerosis
neuropathology and therapeutic development. The scientific event will be
capped off with a networking mixer and neuroscience art silent auction at
the Winnipeg Art Gallery.
Abstracts and registrations are now being accepted. These links and the
program can be found at:
<https://manitobaneuroscience.ca/annual-meeting/2019mnn/>
https://manitobaneuroscience.ca/annual-meeting/2019mnn/
Annual Scientific Meeting | Manitoba Neuroscience Network
manitobaneuroscience.ca
Highlights
Three visiting national speakers
Taco bar lunch (Om nom nom!)
Poster competition
Stellas goodies at coffee breaks
SWAG bags and vendor tables
WAG Networking mixer after-party
Neuroscience art silent auction
And more
The abstract and registration deadline is extended to MAY 17.
Registration takes 5 minutes or less!
NEW this year the student meeting registration rate has been reduced to
only $15. Postdocs and community members are $25 and Faculty are $50.
Discounted rates apply if attending both scientific session and networking
mixer. You may pay by credit card or by University of Manitoba FOP. If you
pay by FOP, you will be registered for the meeting immediately, but your
payment will be pending. Once the FOP payment is processed, you will receive
a receipt and confirmation by email.
MNN Scientific Meeting inquiries should be sent to:
<mailto:info@manitobaneuroscience.ca> info(a)manitobaneuroscience.ca
-The MNN Team
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
We are pleased to announce that the Manitoba Neuroscience Network will again
be accepting applications for 2019/20 TRAVEL AWARDS FOR NEUROSCIENCE
PROJECTS and the 2020 VIKTOR HAVLICEK MEMORIAL NEUROSCIENCE LECTURESHIP.
TRAVEL AWARDS: A legacy fund created by the estate of Nancy Hettie Clark is
used to enrich neuroscience training and support opportunities to network
within the wider neuroscience community. Two travel awards of up to $700
each are intended to be awarded annually to a graduate student and a
postdoctoral fellow at the University of Manitoba. The application deadline
is MAY 20. The eligible travel period is between May 1, 2019 and April 30,
2020, BUT all eligible travel claims must be complete by March 31, 2020.
Eligibility: Eligible trainees are either graduate students or
postdoctoral fellows. Student candidates must be enrolled as full-time
graduate (PhD or MSc) students in the Faculty of Graduate Studies,
University of Manitoba, and have a cumulative graduate grade point average
of 3.5 or greater (University of Manitoba scale). Postdoctoral fellow
candidates must be within the first five years after awarding of their
doctoral degree and have a full-time appointment at the University of
Manitoba or an affiliated hospital or institute. Candidates must demonstrate
excellent research performance and potential in a neurosciences-related
discipline, and must demonstrate they will disseminate research results that
reflect a high-quality contribution by The University of Manitoba.
How to apply: A complete application package consists of the following:
* Cover letter stating the following (1 page maximum):
o Application category (student or postdoctoral fellow) and your start
date in that position
o The conference title, location and dates
o Type of presentation (e.g. poster or oral)
o The importance of the meeting and significance for career development
o Any information that would allow reviewers to assess the significance or
impact of the conference (e.g. abstracts are peer-reviewed)
o Clearly state your graduate GPA (students only)
* Graduate level academic transcript (students only)
* Listing of scholarly output (publications and presentations)
* Support letter from the primary research advisor with (a) a merit
assessment of the candidate and project, and (b) confirmation that there is
a commitment to cover all eligible travel expenses less the award value
* Copy of the submitted abstract
Submit all materials to <mailto:info@manitobaneuroscience.ca>
info(a)manitobaneuroscience.ca by MAY 15. The support letter may be appended
or sent separately by the research advisor.
LECTURESHIP: Viktor Havlicek, MD, PhD, DSc, was a Professor in the
Department of Physiology (now Physiology and Pathophysiology) at the
University of Manitoba from 1968 to 1981. The Viktor Havlicek Memorial fund
was established through gifts to the University of Manitoba in his memory.
This fund yields $3,000 once every two years to support a visit to the
University of Manitoba by an internationally-renowned neuroscientist in a
manner that encourages interactions with trainees.
Applications are now being accepted until MAY 20, 2019 for a visit and
lecture to take place between April 1, 2020 and March 31, 2021.
Applications for the next Lectureship will be accepted in 2021 for 2022/2023
fiscal year.
Nominations must be made by a faculty member but trainees and staff are
encouraged to suggest names to their advisors. Faculty from any MNN
contributing institution (ie. not only the University of Manitoba) may
submit nominations. A complete nomination consists of a letter to the
Neuroscience Awards Committee (NAC) Chair explaining the rationale for
choice of candidate (1 page maximum), along with any supporting materials
the applicant deems useful for assessing the merit of the candidate and the
benefits of his or her visit to the University of Manitoba. Please send
nominations by email to info(a)manitobaneuroscience.ca
<mailto:info@manitobaneuroscience.ca> by May 20.
The NAC will determine an order of invitation priority for submitted
nominees and the top-priority candidate invited at a time determined in
consultation with the nominator. If this candidate is not available, the
next candidate will be invited. All candidates on the priority list must be
considered worthy of the Lectureship by the NAC.
We hope you find these opportunities helpful and exciting. If there are any
questions, you may respond to info(a)manitobaneuroscience.ca
<mailto:info@manitobaneuroscience.ca> .
Thank you.
******************************************
<http://www.manitobaneuroscience.ca/>
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
<https://www.instagram.com/manitobaneuroscience/>
<https://twitter.com/manitobaneuro>
Subject: Reminder: MNN Visiting Speaker - Dr. David Amaral TODAY
[cid:image001.jpg@01D158FE.B69B8D00]
U N I V E R S I T Y O F M A N I T O B A ' S
T H E V I C T O R H A V L I C E K M E M O R I A L L E C T U R E S H I P
RESEARCH LECTURE
D AT E
Tuesday, May 7, 2019
12:00 PM (noon)
LO C AT I O N
Theatre B, BMSB, Bannatyne Campus
(FOLLOWED BY A TRAINEE LUNCH IN SR415)
S P E A K E R
Dr. David Amaral
Professor, Faculty of Medicine
McGill University
T O P I C
The Ups and Downs of Autism Spectrum Disorder: Tracking the trajectories of autism in the Autism Phenome Project
A B S T R A C T
We are attempting to subdivide autism spectrum disorder into more homogeneous subtypes by recruiting a very large cohort of young children (2 - 3 1/2 years of age) into a comprehensive, multidisciplinary and longitudinal analysis of the features of autism. We have also enrolled age-matched typically developing children for comparison. To date, we have enrolled over 450 families into the Autism Phenome Project. In this talk, I will highlight some of the differences in brain development that we have discovered and the behavioral consequences of the different developmental trajectories. I will also provide an overview of data that demonstrates difference in cognitive development in subsets of children with autism. I will also summarize initial findings on the trajectories of autism severity from recent, unpublished analyses. Finally, I will briefly summarize data demonstrating brain changes in children at risk for autism as early as 6 months of age. The goal of these studies is to understand the biological etiologies of different forms of autism which will hopefully lead to more targeted and effective treatments of their debilitating features.
O B J E C T I V E S
1. Gain an understanding of the biological and behavioral heterogeneity of autism spectrum disorder.
2. Become knowledgable about the various developmental trajectories that can be followed by different children with autism spectrum disorder.
3. Understand how it is possible to carry out high quality neuroimaging in young children with neurodevelopmental disorders.
For more information, contact the MNN office @ 204.235.3939
Tabrez Siddiqui
Chair, MNN Seminar Series
E: Tabrez.siddiqui(a)umanitoba.ca<mailto:Tabrez.siddiqui@umanitoba.ca>
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca>
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
[cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/>
[cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>
cid:image001.jpg@01D158FE.B69B8D00
REGISTER NOW!
So you dont miss out, we have extended the MNN meeting deadline to May 17.
The MNN is pleased to announce that the 2019 Scientific Meeting will be held
JUNE 7. The meeting is co-chaired by Dr. Domenico Di Curzio and Dr. Renée
Douville and will be held at the University of Winnipeg. There is an
engaging program planned, featuring a visit and talk by Canadian Research
Council Chair in Developmental Neurogenetics Dr. Daniel Goldowitz
(University of British Columbia) a public lecture by Dr. Janice Robertson
(University of Toronto), a leading expert in Amyotrophic Lateral Sclerosis
neuropathology and therapeutic development. The scientific event will be
capped off with a networking mixer and neuroscience art silent auction at
the Winnipeg Art Gallery.
Abstracts and registrations are now being accepted. These links and the
program can be found at:
<https://manitobaneuroscience.ca/annual-meeting/2019mnn/>
https://manitobaneuroscience.ca/annual-meeting/2019mnn/
Annual Scientific Meeting | Manitoba Neuroscience Network
manitobaneuroscience.ca
Highlights
Three visiting national speakers
Taco bar lunch (Om nom nom!)
Poster competition
Stellas goodies at coffee breaks
SWAG bags and vendor tables
WAG Networking mixer after-party
Neuroscience art silent auction
And more
The abstract and registration deadline is extended to MAY 17.
Registration takes 5 minutes or less!
NEW this year the student meeting registration rate has been reduced to
only $15. Postdocs and community members are $25 and Faculty are $50.
Discounted rates apply if attending both scientific session and networking
mixer. You may pay by credit card or by University of Manitoba FOP. If you
pay by FOP, you will be registered for the meeting immediately, but your
payment will be pending. Once the FOP payment is processed, you will receive
a receipt and confirmation by email.
MNN Scientific Meeting inquiries should be sent to:
mnn2019(a)manitobaneuroscience.ca
-The MNN Team
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: <mailto:kjorund@sbrc.ca> kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480
[cid:image001.jpg@01D158FE.B69B8D00]
**PLEASE SCROLL DOWN TO VIEW INFORMATION ON BOTH A PUBLIC LECTURE (FOLLOWED BY A RECEPTION) AS WELL AS A SCIENTIFIC LECTURE (FOLLOWED BY A TRAINEE LUNCH)
U N I V E R S I T Y O F M A N I T O B A ' S
T H E V I C T O R H A V L I C E K M E M O R I A L L E C T U R E S H I P
PUBLIC LECTURE
D A T E
Monday, May 6th, 2019
8:00 pm
(Followed by refreshments in the Atrium)
L O C A T I O N
Samuel Cohen Auditorium, St. Boniface Hospital Research Centre
S P E A K E R
Dr. David Amaral
Distinguished Professor
Department of Psychiatry & Behavioural Sciences and Center for Neuroscience,
University of California, Davis
CNPRC Core Scientist
T O P I C
Recent Advances in our Understanding of the Causes and Effects of Autism Spectrum Disorder
RESEARCH LECTURE
D AT E
Tuesday, May 7, 2019
12:00 PM (noon)
LO C AT I O N
Theatre B, BMSB, Bannatyne Campus
S P E A K E R
Dr. David Amaral
Distinguished Professor
Department of Psychiatry & Behavioural Sciences and Center for Neuroscience,
University of California, Davis
CNPRC Core Scientist
T O P I C
The Ups and Downs of Autism Spectrum Disorder: Tracking the trajectories of autism in the Autism Phenome Project
A B S T R A C T
We are attempting to subdivide autism spectrum disorder into more homogeneous subtypes by recruiting a very large cohort of young children (2 - 3 1/2 years of age) into a comprehensive, multidisciplinary and longitudinal analysis of the features of autism. We have also enrolled age-matched typically developing children for comparison. To date, we have enrolled over 450 families into the Autism Phenome Project. In this talk, I will highlight some of the differences in brain development that we have discovered and the behavioral consequences of the different developmental trajectories. I will also provide an overview of data that demonstrates difference in cognitive development in subsets of children with autism. I will also summarize initial findings on the trajectories of autism severity from recent, unpublished analyses. Finally, I will briefly summarize data demonstrating brain changes in children at risk for autism as early as 6 months of age. The goal of these studies is to understand the biological etiologies of different forms of autism which will hopefully lead to more targeted and effective treatments of their debilitating features.
O B J E C T I V E S
1. Gain an understanding of the biological and behavioral heterogeneity of autism spectrum disorder.
2. Become knowledgable about the various developmental trajectories that can be followed by different children with autism spectrum disorder.
3. Understand how it is possible to carry out high quality neuroimaging in young children with neurodevelopmental disorders.
For more information, contact the MNN office @ 204.235.3939
Tabrez Siddiqui
Chair, MNN Seminar Series
E: Tabrez.siddiqui(a)umanitoba.ca<mailto:Tabrez.siddiqui@umanitoba.ca>
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca<mailto:kjorund@sbrc.ca>
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
[cid:image003.jpg@01D159B3.9F0B9710]<http://www.manitobaneuroscience.ca/>
[cid:image007.png@01D29326.7E26D480]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image009.jpg@01D29326.7E26D480] <https://www.instagram.com/manitobaneuroscience/> [cid:image010.png@01D29326.7E26D480] <https://twitter.com/manitobaneuro>
cid:image001.jpg@01D158FE.B69B8D00
**PLEASE SCROLL DOWN TO VIEW INFORMATION ON BOTH A PUBLIC LECTURE (FOLLOWED
BY A RECEPTION) AS WELL AS A SCIENTIFIC LECTURE (FOLLOWED BY A TRAINEE
LUNCH)
U N I V E R S I T Y O F M A N I T O B A S
T H E V I C T O R H A V L I C E K M E M O R I A L L E C T U R E S H
I P
PUBLIC LECTURE
D A T E
Monday, May 6th, 2019
8:00 pm
(Followed by refreshments in the Atrium)
L O C A T I O N
Samuel Cohen Auditorium, St. Boniface Hospital Research Centre
S P E A K E R
Dr. David Amaral
Professor, Faculty of Medicine
McGill University
T O P I C
Recent Advances in our Understanding of the Causes and Effects of Autism
Spectrum Disorder
RESEARCH LECTURE
D AT E
Tuesday, May 7, 2019
12:00 PM (noon)
LO C AT I O N
Theatre B, BMSB, Bannatyne Campus
S P E A K E R
Dr. David Amaral
Professor, Faculty of Medicine
McGill University
T O P I C
The Ups and Downs of Autism Spectrum Disorder: Tracking the trajectories of
autism in the Autism Phenome Project
A B S T R A C T
We are attempting to subdivide autism spectrum disorder into more
homogeneous subtypes by recruiting a very large cohort of young children (2
- 3 1/2 years of age) into a comprehensive, multidisciplinary and
longitudinal analysis of the features of autism. We have also enrolled
age-matched typically developing children for comparison. To date, we have
enrolled over 450 families into the Autism Phenome Project. In this talk, I
will highlight some of the differences in brain development that we have
discovered and the behavioral consequences of the different developmental
trajectories. I will also provide an overview of data that demonstrates
difference in cognitive development in subsets of children with autism. I
will also summarize initial findings on the trajectories of autism severity
from recent, unpublished analyses. Finally, I will briefly summarize data
demonstrating brain changes in children at risk for autism as early as 6
months of age. The goal of these studies is to understand the biological
etiologies of different forms of autism which will hopefully lead to more
targeted and effective treatments of their debilitating features.
O B J E C T I V E S
1. Gain an understanding of the biological and behavioral heterogeneity of
autism spectrum disorder.
2. Become knowledgable about the various developmental trajectories that can
be followed by different children with autism spectrum disorder.
3. Understand how it is possible to carry out high quality neuroimaging in
young children with neurodevelopmental disorders.
For more information, contact the MNN office @ 204.235.3939
Tabrez Siddiqui
Chair, MNN Seminar Series
E: Tabrez.siddiqui(a)umanitoba.ca
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Room R4046 - 351 Taché Avenue,
Winnipeg, MB R2H 2A6 CANADA
Email: kjorund(a)sbrc.ca
Tel: 204.235.3939 Fax: 204.237.4092
.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/>
cid:image009.jpg@01D29326.7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480